» Articles » PMID: 2786706

Glycated Fibrinogen: a New Index of Short-term Diabetic Control

Overview
Specialty Biochemistry
Date 1989 Jan 1
PMID 2786706
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrinogen is a plasma protein with a short half-life of four days and, therefore, glycated fibrinogen may be valuable as an index of short-term diabetic control. We have developed a simple, rapid method for determining glycated fibrinogen using affinity chromatography. The differences in the percentage of glycated fibrinogen between normal subjects, well-controlled diabetics and poorly-controlled diabetics were highly significant. There was a significant correlation between glycated fibrinogen and glycated haemoglobin for all these subjects. However, in selected subjects with rapidly improving diabetic control the difference between the fall over three days in glycated fibrinogen and glycated haemoglobin was highly significant. In subjects with deteriorating control over an average of four weeks there was a significant difference between the increase in glycated fibrinogen and glycated haemoglobin. We suggest that glycated fibrinogen may be a valuable adjunct to glucose measurements in the assessment of short-term diabetic control due to its rapid change following alterations in control.

Citing Articles

Fibrinogen post-translational modifications are biochemical determinants of fibrin clot properties and interactions.

Tenopoulou M FEBS J. 2024; 292(1):11-27.

PMID: 39180244 PMC: 11705221. DOI: 10.1111/febs.17236.


Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study.

Yamamoto K, Ito T, Nagasato T, Shinnakasu A, Kurano M, Arimura A Thromb J. 2019; 17:17.

PMID: 31496922 PMC: 6717975. DOI: 10.1186/s12959-019-0206-8.


Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.

Darling A, Uversky V Front Genet. 2018; 9:158.

PMID: 29780404 PMC: 5945825. DOI: 10.3389/fgene.2018.00158.


Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.

Lee S, Hong J, Lee S, Kang D, Ovbiagele B, Demchuk A BMC Neurol. 2017; 17(1):101.

PMID: 28525972 PMC: 5438529. DOI: 10.1186/s12883-017-0865-7.


Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Kearney K, Tomlinson D, Smith K, Ajjan R Cardiovasc Diabetol. 2017; 16(1):34.

PMID: 28279217 PMC: 5345237. DOI: 10.1186/s12933-017-0515-9.